It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Prokineticin-2 (Prok2) is an important secreted protein likely involved in the pathogenesis of several acute and chronic neurological diseases through currently unidentified regulatory mechanisms. The initial mechanical injury of neurons by traumatic brain injury triggers multiple secondary responses including various cell death programs. One of these is ferroptosis, which is associated with dysregulation of iron and thiols and culminates in fatal lipid peroxidation. Here, we explore the regulatory role of Prok2 in neuronal ferroptosis in vitro and in vivo. We show that Prok2 prevents neuronal cell death by suppressing the biosynthesis of lipid peroxidation substrates, arachidonic acid-phospholipids, via accelerated F-box only protein 10 (Fbxo10)-driven ubiquitination, degradation of long-chain-fatty-acid-CoA ligase 4 (Acsl4), and inhibition of lipid peroxidation. Mice injected with adeno-associated virus-Prok2 before controlled cortical impact injury show reduced neuronal degeneration and improved motor and cognitive functions, which could be inhibited by Fbxo10 knockdown. Our study shows that Prok2 mediates neuronal cell deaths in traumatic brain injury via ferroptosis.
Prokineticin-2 (Prok2) is a secreted protein involved in many physiological processes. Here, the authors show that Prok2 prevents neuronal cell ferroptosis after traumatic brain injury and its administration before cortical injury reduces neuronal degeneration, and motor and cognitive impairments.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details





1 the First Affiliated Hospital of Nanjing Medical University, Department of Neurosurgery, Nanjing, China (GRID:grid.412676.0) (ISNI:0000 0004 1799 0784)
2 the Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Department of Neurosurgery, Suzhou, China (GRID:grid.440227.7) (ISNI:0000 0004 1758 3572)
3 Nanjing Medical University, Institute for Stem Cell and Neural Regeneration, School of Pharmacy, Nanjing, China (GRID:grid.89957.3a) (ISNI:0000 0000 9255 8984)
4 Nanjing Medical University, Department of Immunology, Nanjing, China (GRID:grid.89957.3a) (ISNI:0000 0000 9255 8984)
5 LipidALL Technologies Company Limited, Changzhou, China (GRID:grid.511275.5)
6 University of Pittsburgh, Center for Free Radical and Antioxidant Heath, Department of Environmental and Occupational Health, Pittsburgh, USA (GRID:grid.21925.3d) (ISNI:0000 0004 1936 9000); IM Sechenov Moscow State Medical University, Laboratory of Navigational Redox Lipidomics, Moscow, Russian Federation (GRID:grid.448878.f) (ISNI:0000 0001 2288 8774)
7 University of Pittsburgh, Center for Free Radical and Antioxidant Heath, Department of Environmental and Occupational Health, Pittsburgh, USA (GRID:grid.21925.3d) (ISNI:0000 0004 1936 9000); University of Pittsburgh, Safar Center for Resuscitation Research, Department of Critical Care Medicine, Pittsburgh, USA (GRID:grid.21925.3d) (ISNI:0000 0004 1936 9000); UPMC Children’s Hospital of Pittsburgh, Children’s Neuroscience Institute, Pittsburgh, USA (GRID:grid.239553.b) (ISNI:0000 0000 9753 0008)